Boehringer Ingelheim Partners with Microsoft on Digital Patient Twins

Pharmaceutical company Boehringer Ingelheim is collaborating with Microsoft on a project involving digital patient twins.

The partnership aims to use digital patient twins to improve personalized medicine and treatment outcomes.

Digital patient twins are virtual replicas of individual patients, allowing for simulated testing and analysis of treatment options.

The collaboration will leverage Microsoft's Azure cloud platform and Boehringer Ingelheim's expertise in pharmaceutical research and development.